After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

vor 10 Jahren

40 Minuten

Podcast

Podcaster

Medsider: Learn from MedTech and HealthTech Experts

Learn from proven medtech and healthtech experts. That's our primary goal with Medsider. Through uncut interviews with the world's brightest thought leaders, you'll pick up on helpful insights, lessons learned, best practices, and much more.

Wissenschaft , Heilkunde , Interviews , Wirtschaft , Gesundheit & Fitness

Beschreibung

vor 10 Jahren

Jack Dorsey received quite a bit of attention when he was
recently announced as CEO of Twitter. Why? Because
that made him CEO of 2 of the most rapidly-growing tech.
companies in Silicon Valley at the same – Twitter and Square.
Well, medtech’s version of Jack Dorsey might be Duke
Rohlen. Duke led FoxHollow Technologies...[read more]

Related Stories

Why Intersect ENT is an Example of Hope for the Medtech
Industry

Are Medical Device Models the Key to Building a Lean Medtech
Startup?

Substantial and Sustainable – 2 Words That Medtech Companies
Should Get Used To